Targeting resident astrocytes attenuates neuropathic pain after spinal cord injury

  1. Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Orthopaedic Department of Tongji Hospital, School of Medicine, School of Life Sciences and Technology, Tongji University, Shanghai, 200065 P. R. China
  2. Division of Spine, Department of Orthopedics, Tongji Hospital, Tongji University School of Medicine, Tongji University, Shanghai, 200065 P. R. China
  3. Clinical Center for Brain and Spinal Cord Research, Tongji University

Editors

  • Reviewing Editor
    Bamidele Owoyele
    University of Ilorin, Ilorin, Nigeria
  • Senior Editor
    Michael Taffe
    University of California, San Diego, San Diego, United States of America

Reviewer #1 (Public Review):

Summary:

In this study the authors demonstrated that ablation of astrocytes in lumbar spinal cord not only reduced neuropathic pain but also caused microglia activation. Furthermore, RNA sequencing and bioinformatics revealed an activation of STING/type I IFNs signal pathway in spinal cord microglia after astrocyte ablation.

Strengths:

The findings are novel and interesting and provide new insights into astrocyte-microglia interaction in neuropathic pain. This study may also offer a new therapeutic strategy for the treatment of debilitating neuropathic pain in patients with SCI.

Weaknesses:

More details are needed to justify the sample size, statistics, and sex of animals.

Reviewer #2 (Public Review):

Summary:

In the manuscript, Zhao et al. have carried out a thorough examination of the effects of targeted ablation of resident astrocytes on behavior, cellular responses, and gene expression after spinal cord injury. Employing transgenic mice models alongside pharmacogenetic techniques, the authors have successfully achieved the selective removal of these resident astrocytes. This intervention led to a notable reduction in neuropathic pain and induced a shift in microglial cell reactivation states within the spinal cord, significantly altering transcriptome profiles predominantly associated with interferon (IFN) signaling pathways.

Strengths:

The findings presented add considerable value to the current understanding of the role of astrocyte elimination in neuropathic pain, offering convincing evidence that supports existing hypotheses and valuable insights into the interactions between astrocytes and microglial cells, likely through IFN-mediated mechanisms. This contribution is highly relevant and suggests that further exploration in this direction could yield meaningful results.

Weaknesses:

The methodology and evidence underpinning the study are solid, yet some areas would benefit from further clarification, particularly concerning methodological details and the choice of statistical analyses. Additionally, the manuscript's organization and clarity could be improved, as certain figures and schematics appear inconsistent or misleading.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation